PROVECTUS PHARMA NORDIC AS
Provectus Pharma tar helse på alvor | Provectus Pharma AS | Vi tar helse på alvor
Vi prioriterer alltid kvalitet, og ser stadig på løsninger for å forbedre oss, våre produkter og våre kunders opplevelser.
Organization
- Chairman of the board
- EL
- Years since formation
- 4 years
- since Nov 1, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,200
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 20,201,332
- NOK
- Annual total result 2024
- 248,597
- NOK
- Total equity 2024
- 2,151,503
- NOK
Last update: Sep 9, 2025
Management
Board
Name | Role | Shares |
---|---|---|
EL | Chairman | 30 % indirectly |
JA | Board Member | 30 % indirectly |
RL | Board Member | 30 % indirectly |
Others
Name | Role | Shares |
---|---|---|
Accountant | - | |
Auditor | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
EL | Chairman | 30 % indirectly |
JA | Board Member | 30 % indirectly |
RL | Board Member | 30 % indirectly |
MH | - | 10 % indirectly |
Last update: Aug 17, 2023
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 1,200 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -46,685Employees: 0
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 20,201,332 | 23,644,566 | 36,075,200 | 4,663,951 |
Annual Total Result | 248,597 | 234,438 | 1,316,376 | 237,661 |
Total assets | 9,154,458 | 8,638,850 | 7,000,282 | 15,836,690 |
Total liabilities | 7,002,955 | 6,735,945 | 5,331,815 | 15,484,599 |
Total equity | 2,151,503 | 1,902,906 | 1,668,467 | 352,091 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 20,201,332 | 23,644,566 | 36,075,200 | 4,663,951 |
Total operating costs | 19,815,393 | 23,041,470 | 33,085,203 | 4,051,979 |
Operating result | 385,940 | 603,096 | 2,989,998 | 611,972 |
Financial income/costs | -129,638 | -103,545 | -1,298,900 | -305,486 |
Profit before tax | 256,301 | 499,551 | 1,691,097 | 306,486 |
Total tax & extraordinary income/cost | 7,704 | 265,113 | 374,721 | 68,825 |
Annual Total Result | 248,597 | 234,438 | 1,316,376 | 237,661 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 102,000 | 145,000 | 116,000 | 145,000 |
Total current assets | 9,052,458 | 8,493,850 | 6,884,282 | 15,691,690 |
Total assets | 9,154,458 | 8,638,850 | 7,000,282 | 15,836,690 |
Short term debt | 7,002,955 | 6,735,945 | 5,331,815 | 15,484,599 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 7,002,955 | 6,735,945 | 5,331,815 | 15,484,599 |
Contributed capital | 114,430 | 114,430 | 114,430 | 114,430 |
Retained earnings | 2,037,073 | 1,788,476 | 1,554,037 | 237,661 |
Total equity | 2,151,503 | 1,902,906 | 1,668,467 | 352,091 |
Total equity and liabilities | 9,154,458 | 8,638,850 | 7,000,282 | 15,836,690 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises